Company: Novo Nordisk

Founded in 1923, Novo Nordisk is a global healthcare company based in Denmark, specializing in diabetes care and hormone replacement therapy. In the Philippines, Novo Nordisk is dedicated to providing innovative solutions for diabetes management, obesity care, and other chronic diseases. The company focuses on sustainability and corporate responsibility while enhancing the quality of life for patients. With a commitment to research and development, Novo Nordisk aims to deliver breakthrough therapies and education resources, making a significant impact on public health in the region.